BIOMAT Database Logo BIOMAT Database Logo

[Characteristics of the reactogenic and immunogenic properties of killed influence vaccine purified and concentrated by the method of adsorbed chromatography on silicate sorbents]. 1976

T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova

Reactogenic and immunogenic properties of killed influenza vaccine prepared of various strains of influenza virus by the method of sorption chromatography on sliciate sorbents were studied on small groups of volunteers; there proved to be a moderate reactogenic and a marked immunogenic activity of the experimental batches of the preparation. The dose, the concentration and the method of administration of the vaccine to obtain the immune response were determined. The indices of humoral and local immunity following a single vaccination were studied. On the basis of parenteral immunization of donors with killed influenza vaccine there were obtained experimental samples of the antinfluenza gamma-globulin with an increased specific activity.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D007271 Injections, Intradermal The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer. Intradermal Injections,Injection, Intradermal,Intradermal Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova
[Control of killed influenza vaccine purified and concentrated on silicate sorbents].
January 1976, Trudy Instituta imeni Pastera,
T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova
[Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silicate sorbents. I. The immunogenic properties of a vaccine from the A/Victoria/72 strain].
January 1976, Trudy Instituta imeni Pastera,
T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova
[Immunogenic and reactogenic properties of inactivated influenza vaccine purified and concentrated by gradient centrifugation].
January 1982, Trudy Instituta imeni Pastera,
T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova
[Secretory immunity in persons inoculated with killed influenza vaccine purified and concentrated on silicate sorbents].
January 1976, Trudy Instituta imeni Pastera,
T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova
[Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silica sorbents. II. The immunogenic properties of a vaccine from the A/Scotland/74 strain].
January 1976, Trudy Instituta imeni Pastera,
T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova
[Evaluation data from experimental series on a killed influenza vaccine purified and concentrated by differential and density gradient centrifugation. II. The results of a study of the reactogenic properties of the vaccine].
January 1976, Trudy Instituta imeni Pastera,
T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova
[Characteristics of the basic parameters of killed influenza vaccine purified and concentrated on sodium borsilicate glass].
September 1976, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova
[Reactogenic properties and immunologic indiced of adsorbed diphtheria-pertussis-tetanus vaccine].
January 1969, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova
IMMUNOGENIC AND REACTOGENIC PROPERTIES OF LIVE TISSUE CULTURE ANTI-MUMPS VACCINE.
November 1963, Acta virologica,
T V Peradze, and E A Fridman, and V M Kolikov, and M A Bichurina, and V V Goriunova
[Immunogenic and reactogenic properties of commercial series of inactivated chromatographic influenza vaccine].
January 1979, Trudy Instituta imeni Pastera,
Copied contents to your clipboard!